Icosavax, Inc. (ICVX) has a market capitalization of $769.04M and trades at $15.31. The 52-week range is 4.75-16.105.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -6.9, Earnings Per Share (EPS) of $-2.23, annual revenue of $582K.
The stock has a beta of 1.28, operates in the Healthcare sector.
